mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat cardura 2 mg blood pressure cardura 2 mg benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained cardura 2 mg form of doxazosin, to be marketed as Cardura® XL.It is an alpha-1 adrenergic.

HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under cardura 2 mg brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood cardura 2 mg and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form cardura 2 mg doxazosin, to be marketed as cardura 2 mg XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this cardura 2 mg is relaxed vascular smooth muscle tone (vasodilation), which decreases cardura 2 mg vascular resistance, leading to decreased blood pressure. cardura 2 mg Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number.

resistance, leading to decreased blood pressure. DoxazosinFrom Wikipedia, the free.